Hiramoto B, Chan WW. Letter: interpretation of the BESST trial in the context of baseline antidepressant and neuromodulator use. Alimentary Pharmacology & Therapeutics. 2024;59(2):291-292.
Abstract
LINKED CONTENT This article is linked to Parkman et al papers. To view these articles, visit https://doi.org/10.1111/apt.17479 and https://doi.org/10.1111/apt.17838
Last updated on 12/28/2023